Beta-2AR Polymorphysims and Albuterol Responsiveness in Acute Asthma.
Phase of Trial: Phase IV
Latest Information Update: 27 Feb 2017
At a glance
- Drugs Salbutamol (Primary)
- Indications Acute asthma
- Focus Pharmacogenomic; Therapeutic Use
- 11 May 2011 Planned end date changed from 1 Jan 2011 to 1 Jan 2012 as reported by ClinicalTrials.gov.
- 11 May 2011 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 24 Nov 2009 New trial record